AU8838601A - Antiangiogenic agents - Google Patents

Antiangiogenic agents

Info

Publication number
AU8838601A
AU8838601A AU8838601A AU8838601A AU8838601A AU 8838601 A AU8838601 A AU 8838601A AU 8838601 A AU8838601 A AU 8838601A AU 8838601 A AU8838601 A AU 8838601A AU 8838601 A AU8838601 A AU 8838601A
Authority
AU
Australia
Prior art keywords
antiangiogenic agents
antiangiogenic
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU8838601A
Inventor
Gregory Agoston
Jamshed H Shah
Kimberly A Hunsucker
Victor Pribluda
Theresa M Lavallee
Shawn J Green
Christopher J Herbstritt
Xiaoguo H Zhan
Anthony Treston
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Casi Pharmaceuticals Inc
Original Assignee
Entremed Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Entremed Inc filed Critical Entremed Inc
Publication of AU8838601A publication Critical patent/AU8838601A/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
AU8838601A 2000-11-27 2001-08-24 Antiangiogenic agents Pending AU8838601A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US25338500P 2000-11-27 2000-11-27
US25530200P 2000-12-13 2000-12-13
US27825001P 2001-03-23 2001-03-23
US93389401A 2001-08-21 2001-08-21
PCT/US2001/026490 WO2002042319A2 (en) 2000-11-27 2001-08-24 2-substituted estrogens as antiangiogenic agents

Publications (1)

Publication Number Publication Date
AU8838601A true AU8838601A (en) 2002-06-03

Family

ID=27500470

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2001288386A Ceased AU2001288386B2 (en) 2000-11-27 2001-08-24 2-substituted estrogens as antiangiogenic agents
AU8838601A Pending AU8838601A (en) 2000-11-27 2001-08-24 Antiangiogenic agents

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU2001288386A Ceased AU2001288386B2 (en) 2000-11-27 2001-08-24 2-substituted estrogens as antiangiogenic agents

Country Status (5)

Country Link
EP (1) EP1343803A2 (en)
JP (1) JP2004537499A (en)
AU (2) AU2001288386B2 (en)
CA (1) CA2430100A1 (en)
WO (1) WO2002042319A2 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI320712B (en) * 2001-09-05 2010-02-21 Alcon Inc The use of non-feminizing estrogens as retinoprotective agents for the treatment of glaucoma
US20040214806A1 (en) 2002-09-03 2004-10-28 Iok-Hou Pang Use of non-feminizing estrogens as retinoprotective agents for the treatment of glaucoma
DE10307104A1 (en) 2003-02-19 2004-09-23 Schering Ag Anti-tumor effective 2-substituted Estra-1,3,5 (10) -trien-3-yl sulfamate
DE10307103A1 (en) 2003-02-19 2004-09-09 Schering Ag Anti-tumor effective 2-substituted D-homostra-1,3,5 (10) -trien-3-yl sulfamate
CA2546649A1 (en) * 2003-11-26 2005-06-16 Entelos, Inc. Treatment of rheumatoid arthritis with hypoxia-inducible factor 1.alpha. antagonists
TW200611909A (en) 2004-08-04 2006-04-16 Akzo Nobel Nv Process for the preparation 2-substituted-derivatives of estrone and estradiol
TW200613316A (en) 2004-08-26 2006-05-01 Akzo Nobel Nv Process for the preparation of estrone and/or estradiol-derivates
WO2014089177A2 (en) 2012-12-04 2014-06-12 Massachusetts Institute Of Technology Compounds, conjugates and compositions of epipolythiodiketopiperazines and polythiodiketopiperazines
US10201623B2 (en) 2013-03-15 2019-02-12 Memorial Sloan Kettering Cancer Center HSP90-targeted cardiac imaging and therapy
US9850272B2 (en) * 2013-06-25 2017-12-26 Forendo Pharma Ltd. Therapeutically active estratrienthiazole derivatives as inhibitors of 17.beta-hydroxy-steroid dehydrogenase, type 1
EP3013845B1 (en) * 2013-06-25 2020-03-18 Forendo Pharma Ltd Therapeutically active estratrienthiazole derivatives as inhibitors of 17b-hydroxysteroid dehydrogenase, type 1
BR112015031846A8 (en) * 2013-06-25 2018-03-06 Forendo Pharma Ltd stratrientiazole derivatives, their uses, and pharmaceutical composition
US10918627B2 (en) 2016-05-11 2021-02-16 Massachusetts Institute Of Technology Convergent and enantioselective total synthesis of Communesin analogs
US11932650B2 (en) 2017-05-11 2024-03-19 Massachusetts Institute Of Technology Potent agelastatin derivatives as modulators for cancer invasion and metastasis
CN107746420B (en) * 2017-09-28 2020-08-14 湖南新合新生物医药有限公司 Preparation method of 16 beta alkyl steroid compound
US10640508B2 (en) 2017-10-13 2020-05-05 Massachusetts Institute Of Technology Diazene directed modular synthesis of compounds with quaternary carbon centers
WO2020247054A1 (en) 2019-06-05 2020-12-10 Massachusetts Institute Of Technology Compounds, conjugates, and compositions of epipolythiodiketopiperazines and polythiodiketopiperazines and uses thereof

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB857081A (en) * 1956-05-29 1960-12-29 Syntex Sa Cyclopentanophenanthrene derivatives and process for the production thereof
US3166577A (en) * 1956-05-29 1965-01-19 Syntex Corp 1, 2-dimethyl estrogens and intermediates used in the production thereof
GB857080A (en) * 1956-05-29 1960-12-29 Syntex Sa Cyclopentanophenanthrene derivatives and process for the production thereof
US2846453A (en) * 1957-05-28 1958-08-05 Searle & Co Alpha-ring-acylated estrone derivatives, and corresponding alcohols, their esters, and ethers
US3562260A (en) * 1965-08-23 1971-02-09 Ormonoterapia Richter Spa 2-carbonyl-estratrienes and method of their preparation
DE2004516A1 (en) * 1969-03-05 1970-09-10 VEB Jenapharm, Jena Thermpentic steroidal sulphonate esters
EP0243449A1 (en) * 1985-10-18 1987-11-04 The Upjohn Company Cyclic hydrocarbons with an aminoalkyl sidechain
JP2517561B2 (en) * 1986-10-03 1996-07-24 新技術事業団 Category Estrogen Immunoassay Kit
DE3872234T2 (en) * 1987-04-16 1993-01-07 Upjohn Co CYCLIC HYDROCARBONS WITH AMINOALKYL SIDE CHAIN.
US5504074A (en) * 1993-08-06 1996-04-02 Children's Medical Center Corporation Estrogenic compounds as anti-angiogenic agents
EP0791660A1 (en) * 1996-02-22 1997-08-27 Smithkline Beecham Corporation A novel diagnostic marker for splicing variants of genes associated with neurological function
US5763432A (en) * 1997-01-29 1998-06-09 Sri International Steriod inhibitors of estrone sulfatase and associated pharmaceutical compositions and methods of use
US6136992A (en) * 1997-03-13 2000-10-24 The United States Of America As Represented By The Department Of Health And Human Services 2-alkoxy estradiols and derivatives thereof
CA2208916A1 (en) * 1997-07-03 1999-01-03 Hyal Pharmaceutical Corporation Promotion of wound healing utilizing steroids having reduced deterioroussystemic side effects typical of glucocorticoids, mineralocorticoids andsex steroids
US6046186A (en) * 1997-12-24 2000-04-04 Sri International Estrone sulfamate inhibitors of estrone sulfatase, and associated pharmaceutical compositions and methods of use
US6054446A (en) * 1997-12-24 2000-04-25 Sri International Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
CA2339368A1 (en) * 1998-08-07 2000-02-17 Endorecherche, Inc. Inhibitors of type 3 3.alpha.-hydroxysteroid dehydrogenase
WO2000010552A2 (en) * 1998-08-24 2000-03-02 Global Vascular Concepts, Inc. Use of anti-angiogenic agents for inhibiting vessel wall injury
EP1173182A2 (en) * 1999-04-30 2002-01-23 Sterix Limited Use of estrone derivatives as antitumour agents
GB9910934D0 (en) * 1999-05-11 1999-07-14 Res Inst Medicine Chem Chemical compounds
AUPQ342599A0 (en) * 1999-10-14 1999-11-04 University Of Melbourne, The Conjugates and uses thereof
KR100740354B1 (en) * 2000-05-11 2007-07-26 리서치 인스티튜트 포 메디신 앤드 케미스트리 인코포레이티드 2-Substituted Pregna-1,3,510-Triene and Chola-1,3,510-Triene Derivatives and Their Biological Activity

Also Published As

Publication number Publication date
CA2430100A1 (en) 2002-05-30
WO2002042319A9 (en) 2005-03-31
WO2002042319A3 (en) 2003-03-13
JP2004537499A (en) 2004-12-16
EP1343803A2 (en) 2003-09-17
AU2001288386B2 (en) 2006-11-02
WO2002042319A2 (en) 2002-05-30

Similar Documents

Publication Publication Date Title
HK1056165A1 (en) Glucocortiocoid-selective antiinflammatory agents
AU3391801A (en) Pyridinylimidazoles
HUP0303043A3 (en) Rhinological agents
AU8274301A (en) Electro-powder
IL155519A0 (en) Antiinflammation agents
AU6803901A (en) Bis-arylsulfones
AU8838601A (en) Antiangiogenic agents
DE50102859D1 (en) Hochfliessfähige propylenblockcopolymerisate
AU9385201A (en) Sulfonylguanidine
DE50008626D1 (en) Substituierte aminomethyl-phenyl-cyclohexanderivate
AU6619001A (en) Liquid-pourers
DE50008447D1 (en) Aminomethyl-phenyl-cyclohexanonderivate
AU4686401A (en) Hypotensors
AU9187601A (en) Triazolo-epothilones
DE50006446D1 (en) Otoplastik
EP1291461A4 (en) Color-recovering agent
AU4831301A (en) Gm-negative ehv-mutants
AU8756801A (en) Thienopyrrolidinones
DE50003404D1 (en) Multi-master-bus-system
DE50103809D1 (en) Hydrocephalusventil
GB0015654D0 (en) Bath
GB0012417D0 (en) Giovelette
GB0025070D0 (en) Contrast agents
GB0009042D0 (en) Contrast agents
AU1702P (en) Trailblazer Xanthostemon chrysanthus